Tobira Therapeutics
(TBRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2012 | 12-2011 | |
| Operating Expenses | 2,581 | 0 |
| Operating Income | -2,581 | 0 |
| Interest Expense | 137 | 0 |
| Other Income | 1 | 0 |
| Pre-tax Income | -2,717 | 0 |
| Net Income Continuous | -2,717 | 0 |
| Net Income | $-2,717 | $0 |
| EPS Basic Total Ops | -110.53 | N/A |
| EPS Basic Continuous Ops | -110.52 | N/A |
| EPS Diluted Total Ops | -110.53 | N/A |
| EPS Diluted Continuous Ops | -110.52 | N/A |
| EBITDA(a) | $-2,581 | $0 |